AbbVie Inc. Competitors

ABBV 
$58
*  
0.35
0.61%
Get ABBV Alerts
*Delayed - data as of Mar. 30, 2015 9:36 ET  -  Find a broker to begin trading ABBV now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ABBV Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

AbbVie Inc.

CompanyName
Symbol: Market
LastSale NetChange ▼ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Auspex Pharmaceuticals, Inc.
ASPX: NASDAQ-GM
$ 100.40 29.49 ▲ 1,149,304 $ 100.54
$ 100.30
$ 88.21
$ 14.75
NE 3,078,665,600
Receptos, Inc.
RCPT: NASDAQ-GS
$ 152.234 4.80 ▲ 77,394 $ 155.41
$ 150
$ 156.8299
$ 24.5345
NE 4,796,284,404
Puma Biotechnology Inc
PBYI: NYSE
$ 220.0401 4.04 ▲ 7,697 $ 222
$ 218.9904
$ 279.37
$ 53.63
NE 7,023,459,952
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 458.20 3.70 ▲ 68,035 $ 461.416
$ 457.51
$ 495.50
$ 269.50
149.74 46,115,539,000
Valeant Pharmaceuticals International, Inc.
VRX: NYSE
$ 201.33 3.49 ▲ 84,252 $ 201.62
$ 198.32
$ 206.84
$ 106
75.4 67,687,749,990
Horizon Pharma plc
HZNP: NASDAQ-GS
$ 25.035 3.23 ▲ 1,629,721 $ 25.50
$ 24.78
$ 23.45
$ 7.85
NE 3,131,878,500
Hyperion Therapeutics, Inc.
HPTX: NASDAQ-GS
$ 45.90 3.16 ▲ 2,627,115 $ 45.94
$ 45.82
$ 45.40
$ 20.23
NE 951,185,700
Actavis, Inc.
ACT: NYSE
$ 306.41 2.85 ▲ 109,202 $ 307.82
$ 305.62
$ 317.72
$ 184.71
NE 81,582,275,320
United Therapeutics Corporation
UTHR: NASDAQ-GS
$ 175.81 2.85 ▲ 29,781 $ 177.17
$ 174.605
$ 181.61
$ 84.63
28.49 8,204,349,460
Anacor Pharmaceuticals, Inc.
ANAC: NASDAQ-GM
$ 57.13 2.28 ▲ 41,731 $ 57.99
$ 55.6165
$ 58.08
$ 13.19
NE 2,450,705,610
Alnylam Pharmaceuticals, Inc.
ALNY: NASDAQ-GS
$ 106.197 2.14 ▲ 40,844 $ 107.49
$ 104.99
$ 121.93
$ 47.03
NE 8,895,060,720
Alexion Pharmaceuticals, Inc.
ALXN: NASDAQ-GS
$ 182.6262 2.04 ▲ 56,991 $ 183.73
$ 180.86
$ 203.30
$ 136.37
56.02 36,917,703,704
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 98.57 1.97 ▲ 40,110 $ 101
$ 97.76
$ 138.85
$ 31.42
NE 3,668,578,260
Tetraphase Pharmaceuticals, Inc.
TTPH: NASDAQ-GS
$ 37.95 1.80 ▲ 55,189 $ 38.174
$ 36.99
$ 44.55
$ 8.01
NE 1,163,471,100
Medivation, Inc.
MDVN: NASDAQ-GS
$ 133.75 1.76 ▲ 51,915 $ 135.97
$ 133.57
$ 141.58
$ 54.37
40.04 10,463,663,750
Intercept Pharmaceuticals, Inc.
ICPT: NASDAQ-GS
$ 295.60 1.69 ▲ 109,500 $ 303.94
$ 292.5216
$ 349.08
$ 128.50
NE 6,625,874,000
Esperion Therapeutics, Inc.
ESPR: NASDAQ-GM
$ 92.33 1.68 ▲ 89,395 $ 93.065
$ 92.07
$ 118.95
$ 12.75
NE 1,885,932,580
Perrigo Company
PRGO: NYSE
$ 167.56 1.59 ▲ 45,933 $ 168.04
$ 167.49
$ 174.65
$ 125.37
65.2 23,591,610,200
Ligand Pharmaceuticals Incorporated
LGND: NASDAQ-GM
$ 74.51 1.56 ▲ 10,414 $ 74.80
$ 74.06
$ 79.61
$ 41.99
130.72 1,458,756,780
Lannett Co Inc
LCI: NYSE
$ 67.058 1.55 ▲ 41,882 $ 67.3799
$ 66
$ 71.26
$ 29.12
19.61 2,400,810,516
BioMarin Pharmaceutical Inc.
BMRN: NASDAQ-GS
$ 130.27 1.49 ▲ 289,396 $ 133.44
$ 130.06
$ 133.54
$ 55.04
NE 20,712,930,000
Insys Therapeutics, Inc.
INSY: NASDAQ-GM
$ 57.73 1.47 ▲ 27,405 $ 58.25
$ 56.51
$ 62.48
$ 20.52
56.05 2,018,125,340
Endo International plc
ENDP: NASDAQ-GS
$ 91.385 1.35 ▲ 87,161 $ 91.61
$ 90.16
$ 93.03
$ 53.62
NE 15,783,011,965
Celgene Corporation
CELG: NASDAQ-GS
$ 119.992 1.31 ▲ 546,076 $ 120.50
$ 119.51
$ 129.06
$ 66.85
50 96,064,515,272
Ultragenyx Pharmaceutical Inc.
RARE: NASDAQ-GS
$ 57.85 1.29 ▲ 32,905 $ 59
$ 56.16
$ 64.99
$ 32.02
NE 2,020,989,750